** Shares of dental products maker Align Technology rise 2.6% to $322 in extended trading
** ALGN raises annual revenue growth forecast after topping estimates for Q1 profit
** Company now sees FY2024 total revenue growth up 6% to 8% YOY, compared with previously expected rise of mid-single digit over 2023
** Expects Q2 total sales to be between $1.03 bln and $1.05 bln, meeting analysts' estimates at mid-point
** On an adj. basis, ALGN earned $2.14/shr for the first quarter ended March, above analysts' average est. of $1.97/shr - LSEG
** Up to last close, stock has risen 14.48%
(Reporting by Juby Babu in Bengaluru)
((Juby.Babu@thomsonreuters.com;))
Comments